Back to Market Feed

ALOGLIPTIN 6.25 MG TABLET

Alogliptin
$4.8474per EA

Strength

6.25 mg/1

NDC

45802008765

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ALOGLIPTIN BENZOATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022271

On Market Since

4/8/2016

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-2.8%

1Y

-6.2%

3Y

-1.2%

5Y

-10.6%

All

-13.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470677•Mylan Pharmaceuticals Inc.
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470693•Mylan Pharmaceuticals Inc.
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082630•Aurobindo Pharma Limited
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082690•Aurobindo Pharma Limited
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072730•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072790•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470577•Mylan Pharmaceuticals Inc.
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470593•Mylan Pharmaceuticals Inc.
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082530•Aurobindo Pharma Limited
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082590•Aurobindo Pharma Limited
$1.2833
per EA